“Clinical research conducted with various curcumin preparations indicate therapeutic benefits for a multitude of inflammatory-based disorders (e.g., arthritis), wound healing, diabetes, Alzheimer’s disease, cardiovascular disease, and cancer.
This monograph covers only those clinical studies conducted on BCM-95, an ingredient which was developed with the goal of improving the bioavailability of curcumin.
BCM-95 has been clinically evaluated for the following conditions: major depressive disorder, cognitive health, Alzheimer’s disease, osteoarthritis, rheumatoid arthritis, oral submucous fibrosis, oral leukoplakia, and to mitigate adverse effects from radiation therapy in patients with prostate cancer.”
-Excerpt from Proprietary Botanical Ingredient Scientific and Clinical Monograph for BCM-95® / CurcugreenTM
Curcumin BCM-95 Resources
- BCM-95 Research Review from American Botanical Council
- Monograph on BCM-95 from American Botanical Council
- Supplements with BCM-95
